Hailiang K. Zhang

Shanghai, 200030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 138 publications

APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

Journal: Science advances

Published: August 07, 2026

Prostate-Specific Membrane Antigen PET-Guided Salvage Radiotherapy-Precision or Prematurity?

Prostate-Specific Membrane Antigen PET-Guided Salvage Radiotherapy-Precision or Prematurity?

Journal: JAMA oncology

Published: February 05, 2026

Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo).

Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo).

Journal: European urology

Published: October 23, 2025

Re: Laurence Albiges, Thomas Powles, Anand Sharma, et al. CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor-based Combination Therapy in Patients with Metastatic Renal Cell Carcinoma. Eur Urol. 2026;89:210-19.

Re: Laurence Albiges, Thomas Powles, Anand Sharma, et al. CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor-based Combination Therapy in Patients with Metastatic Renal Cell Carcinoma. Eur Urol. 2026;89:210-19.

Journal: European urology

Published: October 18, 2025

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 23, 2025

Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.

Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.

Journal: Nature biomedical engineering

Published: September 22, 2025

Decoding the tumor microenvironment: insights into immunotherapy and beyond.

Decoding the tumor microenvironment: insights into immunotherapy and beyond.

Journal: Journal of the National Cancer Center

Published: August 15, 2025

Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer.

Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer.

Journal: Frontiers in cell and developmental biology

Published: July 28, 2025

Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial Carcinoma.

Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial Carcinoma.

Journal: JCO precision oncology

Published: July 25, 2025

Proteogenomic Analysis Identifies Clinically Relevant Subgroups of Collecting Duct Carcinoma.

Proteogenomic Analysis Identifies Clinically Relevant Subgroups of Collecting Duct Carcinoma.

Journal: Research (Washington, D.C.)

Published: June 04, 2025

Bavachalcone targets transferrin receptor and sensitizes gemcitabine to affect bladder cancer progression.

Bavachalcone targets transferrin receptor and sensitizes gemcitabine to affect bladder cancer progression.

Journal: iMeta

Published: May 23, 2025

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies.

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies.

Journal: MedComm

Published: May 18, 2025

Showing 1-12 of 138

Last Updated: 09/26/2026